ASCO Audio Journal of Oncology – June 1st, 2006 – In the company of Gordon McVie

REFERENCE: 5th European Breast Cancer Conference, Nice, 21st – 25th March 2006
Robin Zon, Michiana Hematology Oncology, South Bend, Indiana
Bevacizumab could be a new treatment option in metastatic breast cancer, according to a study reported at the 5th European Breast Cancer conference in Nice. Derek Thorne spoke to Robin Zon of Michiana Hematology Oncology, in South Bend Indiana, about the study findings.

REFERENCE: Cancer, 2006, May 8
André Konski, Fox Chase Cancer Center, Philadelphia
Does age matter when selecting a treatment for patients with early stage prostate cancer? A study reported in the journal Cancer suggests it may not. André Konski told Derek Thorne about a retrospective study carried out at the Fox Chase Cancer Center in Philadelphia.

REFERENCE: Journal of Clinical Oncology 2006; 24:605
Bridget Koontz, Duke University Medical Center, Durham
In early stage Hodgkin’s Disease many doctors are now using combined modality therapy, involving chemotherapy and a lower dose of radiation. Bus is it any safer than radiation alone? A retrospective study from Duke University Medical Center suggests that it is. Derek Thorne got the details from Bridget Koontz.

[audio:https://www.audiomedica.com/podcasting/asco/06.06.01_AJONC_podcast.mp3]